During the past decade, Gabinet Endoskopii Przewodu Pokarmowego conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 10 clinical trials were completed, i.e. on average, 90.9% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 7 clinical trials were completed. i.e. 350% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gabinet Endoskopii Przewodu Pokarmowego" #1 sponsor was "Takeda" with 5 trials, followed by "Galapagos NV" with 4 trials sponsored, "Pfizer" with 3 trials sponsored, "Shire" with 2 trials sponsored and "Alimentiv Inc." with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gabinet Endoskopii Przewodu Pokarmowego" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Gabinet Endoskopii Przewodu Pokarmowego" are "Ulcerative Colitis" (8 trials), "Colitis, Ulcerative" (4 trials), "Crohn's Disease" (4 trials) and "Gastroesophageal Reflux" (1 trials). Many other conditions were trialed in "Gabinet Endoskopii Przewodu Pokarmowego" in a lesser frequency.

Most popular intervention types in "Gabinet Endoskopii Przewodu Pokarmowego" are "Drug" (15 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Filgotinib" (5 trials), "CP-690,550" (2 trials), "225mg SHP647 (PF-00547659)" (1 trials) and "75mg SHP647 (PF-00547659)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gabinet Endoskopii Przewodu Pokarmowego" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Gabinet Endoskopii Przewodu Pokarmowego". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 11 completed trials in Gabinet Endoskopii Przewodu Pokarmowego, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gabinet Endoskopii Przewodu Pokarmowego, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".